As of Feb 28, 2025
American Century ETF Trust Avantis Responsible International Equity ETF (ARCA: AVSD)
Ticker | Name | Share % | |
---|---|---|---|
CO | Novo Nordisk A/S ADR | 1.02% | |
SM | Roche Holding Ag | 0.79% | |
ASML | Asml Holding Nv (new York Registered) | 0.93% | |
HSBC | HSBC Holdings Plc (ADR) | 0.93% | |
AZN | Astrazeneca Plc ( Azn ) | 0.76% | |
PA | Cie De Saint-gobain Common Stock Eur4.0 | 0.66% | |
CA | Royal Bank Of Canada | 0.60% | |
AS | Asml Holding Nv | 0.72% | |
AU | Commonwealth Bank Of Australia | 0.65% |
The AVSD ETF is currently trading at $60.07, which represents a -0.07% change. Over the past 52 weeks, the ETF has traded as high as $62.13 and as low as $53.50.
The expense ratio of AVSD is 0.23%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for AVSD is 158.72M. This represents the total market value of the assets managed by the ETF.
AVSD follows a Large Cap Blend investment style.
The top holdings of AVSD include: CO (1.02%), SM (0.79%), ASML (0.93%), HSBC (0.93%), AZN (0.76%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for AVSD is currently not available.